Editor’s note: Following is Tuesday’s testimony of Peter Lurie, MD, MPH, President and Executive Director, CSPI, before the U.S. House of Representatives Committee on Oversight and Accountability Subcommittee on Health Care and Financial Services

I want to thank Chairwoman McClain, Ranking Member Porter, and other committee members

Continue Reading Testimony from the head of the Center for Science in the Public Interest on the infant formula crisis

A congressional subcommittee hearing Tuesday on the infant formula crisis of 2022 not only explored how the crisis occurred but also examined how the structure of the FDA hampered efforts to resolve the situation and how ineffective management from the top continues to plague the agency.

The hearing Tuesday before

Continue Reading Witnesses tell congressional subcommittee that infant formula crisis was example of FDA problems